Li Ai
Impact in
Papers in
- Physiology 10
- Obstructive Sleep Apnea Research 9
- Oncology 6
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Abraham Anderson (1 shared paper)Howard L. Kaufman (1 shared paper)Omid Hamid (1 shared paper)David R. Minor (1 shared paper)Igor J. Puzanov (1 shared paper)Jeffrey Chou (1 shared paper)Robert H.I. Andtbacka (1 shared paper)Kevin S. Gorski (1 shared paper)
- Journals
- General Hospital Psychiatry (2 papers)Journal of Clinical Oncology (2 papers)Nature and Science of Sleep (2 papers)BMC Pulmonary Medicine (1 paper)Tissue Barriers (1 paper)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Li Ai
53 papers receiving 3.6k citations
Li Ai's Hit Papers
Peers
Comparison fields: 5 of 114
- Oncology 1.3k
- Genetics 1.2k
- Drug Discovery 8
- Immunology 472
- Genetics 85
Countries citing papers authored by Li Ai
This map shows the geographic impact of Li Ai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Ai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Ai more than expected).
Fields of papers citing papers by Li Ai
This network shows the impact of papers produced by Li Ai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Ai. The network helps show where Li Ai may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Ai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma Hit paper breakdown → | 2015 | 2166 |
| 2 | Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma Hit paper breakdown → | 2016 | 491 |
| 3 | 2007 | 121 | |
| 4 | 2021 | 94 | |
| 5 | 2021 | 93 | |
| 6 | 2006 | 91 | |
| 7 | 2008 | 64 | |
| 8 | 2020 | 52 | |
| 9 | 2015 | 45 | |
| 10 | 2015 | 44 | |
| 11 | 2020 | 43 | |
| 12 | 2015 | 38 | |
| 13 | 2007 | 29 | |
| 14 | 2016 | 27 | |
| 15 | 2013 | 20 | |
| 16 | 2023 | 20 | |
| 17 | 2017 | 19 | |
| 18 | 2010 | 17 | |
| 19 | 2010 | 17 | |
| 20 | 2023 | 16 |
About Li Ai
Li Ai is a scholar working on Physiology, Oncology, Infectious Diseases, Cancer Research and Pulmonary and Respiratory Medicine, having authored 54 papers that have together received 3.7k indexed citations. Recurring topics across this work include Obstructive Sleep Apnea Research (9 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), COVID-19 Clinical Research Studies (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Pancreatic function and diabetes (2 papers), Traumatic Brain Injury and Neurovascular Disturbances (2 papers), Mental Health Treatment and Access (2 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). The work is most often cited by research in Oncology (1.3k citations), Genetics (1.2k citations), Drug Discovery (8 citations), Immunology (472 citations) and Genetics (85 citations). Li Ai has collaborated with scholars based in China, United States and France. Frequent co-authors include Abraham Anderson, Howard L. Kaufman, Omid Hamid, David R. Minor, Igor J. Puzanov, Jeffrey Chou, Robert H.I. Andtbacka, Kevin S. Gorski, Michael A. Chastain and Mohammed M. Milhem. Their work appears in journals such as General Hospital Psychiatry, Journal of Clinical Oncology, Nature and Science of Sleep, BMC Pulmonary Medicine and Tissue Barriers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.